Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT03150810 · COMPLETED
Trial details
- NCT number
- NCT03150810
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-28
- Primary completion
- 2023-05-04
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.